Leading injection moulder, Boddingtons, will return to this weeks’ Medical Technology Ireland exhibition, offering added value and benefits for Irish-based businesses.
The UK-based supplier of manufacturing services has once again posted double-digit growth through 2022 and has further expanded its Class 7 cleanroom capabilities and services.
Andy Tibbs, Boddingtons CEO, says that ‘Boddingtons always finds value in this prestigious event for the Irish medical industry. We believe we have many advantages to offer the Irish and UK medical markets. We look forward to the show and are open to sharing our opportunities and resources in both markets for ‘win-win’ outcomes.
Medical Technology Ireland will take place at Galway Racecourse on September 21-22, 2022. Over 200 suppliers to the industry will exhibit alongside an innovative conference programme.
Jason Moss, Show Director, comments that ‘our medical exhibition operations in Ireland and the UK have gone from strength to strength in the last 18 months, and Boddingtons has been a key part of our success over that time. As ever, our success is the success of our customers. Once again – a huge thank you to all the exhibitors who will be with us in Galway this week.’
Medical device manufacturer Boddingtons Plastics offers Class 7 cleanroom manufacturing for the production of Class 1 and Class 2 medical devices. These operations are supported by international quality management systems with complete regulatory compliance services on all five continents.
Boddingtons operates a state-of-the-art facility in South East England for the production of injection-moulded components, medical devices and assemblies. All manufacturing is included within the scope of ISO 13485 and MDSAP accreditations.
Boddingtons has won the prestigious Plastics Industry Awards (PIA) a record-breaking four times for its design-for-manufacture expertise. Three of these awards have been for medical devices.
From concept design, tooling, validation, and CE marking to Medical Device registrations, Boddingtons supplies a fully managed programme, helping customers with new product introductions and increase of market share.
Recent investments at Boddingtons include Fanuc, Arburg and Engel machinery; a Mitutoyo Quick Vision Active CMM system with Touch Probe and further Class 7 cleanroom expansions.
Since the launch of its new £4.6m manufacturing facility in early 2017, Boddingtons has steadily expanded the scope and volume of its med-tech manufacturing services. The company is certified to ISO13485 and ISO9001 Quality Management Systems Requirements and is also compliant with FDA 21 CFR Part 820.
Read more news from Boddingtons here.
